Who is sponsoring NCT07589322?

NCT07589322 is sponsored by Tri-Service General Hospital.

What drugs are being tested in NCT07589322?

Interventions in NCT07589322: Tirzepatide with lifestyle modification, Semaglutide with lifestyle modification.

What condition does NCT07589322 study?

NCT07589322 studies Obesity and Metabolic Syndrome.

Is NCT07589322 still recruiting?

NCT07589322 is currently recruiting now.

Last reviewed 2026-06-10 · How we verify

NCT07589322

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

Recruiting now NA

What this trial tests

NA trial testing Tirzepatide with lifestyle modification in Obesity and Metabolic Syndrome in 120 participants. Currently enrolling.

Timeline

31 March 2026

30 September 2029

Quick facts

Lead sponsor	Tri-Service General Hospital
Phase	NA
Status	Recruiting now
Enrollment	120
Start date	31 March 2026
Estimated completion	30 September 2029

Drugs / interventions tested

Tirzepatide with lifestyle modification
Semaglutide with lifestyle modification

Conditions studied

Obesity and Metabolic Syndrome — all drugs for Obesity and Metabolic Syndrome →

Sponsor

Tri-Service General Hospital

Who can join

Eligibility, any sex, with Obesity and Metabolic Syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tri-Service General Hospital trials

Trials by the same sponsor.

NCT07515495 — Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for "My Heal · NA · recruiting
NCT07327385 — To Investigate the Change of Brain and Autonomic Function From Different Protocols of Repeated Transcranial Magnetic Sti · NA · not yet recruiting
NCT07355023 — AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Targe · NA · recruiting
NCT07241182 — Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy · NA · recruiting
NCT06932614 — Comparing the Efficacy of Lyophilized Self Growth Factor Versus PRP Injection for Knee OA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07589322 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tri-Service General Hospital
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07589322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing